Lenka Palova Jelinkova
Director - Translational Science SOTIO Biotech
Seminars
Monday 3rd November 2025
Exploring Novel Pharmacology & Translational Aspects of SOT106 Targeting LRRC15 in Solid Tumors
10:30 am
- Describing pharmacological characterization of SOT106, including LRRC15 expression within different cell populations in the TME with emphasis on pivotal role in tumor biology
- Developing SOT106 diagnostic antibody tailored to optimize patient selection and identify patients who could benefit
- Exploring the prospect of SOT106 combination therapies to elevate therapeutic potential
